Literature DB >> 23050466

Infectious bronchitis virus subpopulations in vaccinated chickens after challenge.

Haroldo Toro1, Daniela Pennington, Rodrigo A Gallardo, Vicky L van Santen, Frederik W van Ginkel, JianFeng Zhang, Kellye S Joiner.   

Abstract

Infectious bronchitis coronavirus (IBV) shows extensive genotypic and phenotypic variability. The evolutionary process involves generation of genetic diversity by mutations and recombination followed by replication of those phenotypes favored by selection. In the current study, we examined changes occurring in a wild Arkansas (Ark) challenge strain in chickens that were vaccinated either ocularly with commercially available attenuated ArkDPI-derived vaccines or in ovo with a replication-defective recombinant adenovirus expressing a codon-optimized IBV Ark S1 gene (AdArkIBV.S1(ck)). Commercial IBV Ark vaccines A, B, and C provided slightly differing levels of protection against homologous challenge. Most importantly for the current study, chickens vaccinated with the different vaccines displayed significant differences in specific B-lymphocyte responses in the Harderian gland (i.e., the challenge virus encountered differing immune selective pressure during invasion among host groups). Based on S1 sequences, five predominant populations were found in different individual vaccinated/challenged chickens. Chickens with the strongest immune response (vaccine A) were able to successfully impede replication of the challenge virus in most chickens, and only the population predominant in the challenge strain was detected in a few IBV-positive birds. In contrast, in chickens showing less than optimal specific immune responses (vaccines B and C) IBV was detected in most chickens, and populations different from the predominant one in the challenge strain were selected and became predominant. These results provide scientific evidence for the assumption that poor vaccination contributes to the emergence of new IBV strains via mutation and/or selection. In ovo vaccination with a low dose of AdArkIBV.S1(ck) resulted in a mild increase of systemic antibody and reduced viral shedding but no protection against IBV signs and lesions. Under these conditions we detected only virus populations identical to the challenge virus. Possible explanations are discussed. From a broad perspective, these results indicate that selection is an important force driving IBV evolution.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23050466     DOI: 10.1637/9982-110811-Reg.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  11 in total

1.  Evaluation of Cholera Toxin Adjuvanticity Effect on the Production of Specific Antibodies Induced by Avian Infectious Bronchitis Vaccine in Chickens.

Authors:  A Khastar; H Farzin; M Jamshidian Mojaver
Journal:  Arch Razi Inst       Date:  2022-02-28

2.  Genome-wide profiling of chicken dendritic cell response to infectious bursal disease.

Authors:  Jian Lin; Jing Xia; Keyun Zhang; Qian Yang
Journal:  BMC Genomics       Date:  2016-11-05       Impact factor: 3.969

3.  Molecular characterization and phylogenetic analyses of virulent infectious bronchitis viruses isolated from chickens in Eastern Saudi Arabia.

Authors:  Maged Gomaa Hemida; Mohammed A Al-Hammadi; Abdul Hafeed S Daleb; Cecilio R Gonsalves
Journal:  Virusdisease       Date:  2017-05-09

4.  Effect of Pullet Vaccination on Development and Longevity of Immunity.

Authors:  Emily J Aston; Brian J Jordan; Susan M Williams; Maricarmen García; Mark W Jackwood
Journal:  Viruses       Date:  2019-02-02       Impact factor: 5.048

Review 5.  The avian coronavirus spike protein.

Authors:  I N Ambepitiya Wickramasinghe; S J van Beurden; E A W S Weerts; M H Verheije
Journal:  Virus Res       Date:  2014-10-17       Impact factor: 3.303

6.  Insights from molecular structure predictions of the infectious bronchitis virus S1 spike glycoprotein.

Authors:  Christina Lora M Leyson; Brian J Jordan; Mark W Jackwood
Journal:  Infect Genet Evol       Date:  2016-11-09       Impact factor: 3.342

7.  Evaluation of the genetic variability found in Brazilian commercial vaccines for infectious bronchitis virus.

Authors:  Giuliana Loreto Saraiva; Marcus Rebouças Santos; Claiton Gonçalves Pereira; Pedro Marcus Pereira Vidigal; Juliana Lopes Rangel Fietto; Tiago Antonio de Oliveira Mendes; Gustavo Costa Bressan; Jamária A P Soares-Martins; Márcia Rogéria de Almeida; Abelardo Silva-Júnior
Journal:  Virus Genes       Date:  2017-11-11       Impact factor: 2.332

8.  Adjuvant Effects of Platycodin D on Immune Responses to Infectious Bronchitis Vaccine in Chickens.

Authors:  Yefei Zhou; Meixian Zhou; Shanguo Mao
Journal:  J Poult Sci       Date:  2020-04-25       Impact factor: 1.425

9.  Polymorphisms in the S1 spike glycoprotein of Arkansas-type infectious bronchitis virus (IBV) show differential binding to host tissues and altered antigenicity.

Authors:  Christina Leyson; Monique França; Mark Jackwood; Brian Jordan
Journal:  Virology       Date:  2016-09-15       Impact factor: 3.616

10.  Protection against infectious bronchitis virus by spike ectodomain subunit vaccine.

Authors:  Fatma Eldemery; Kellye S Joiner; Haroldo Toro; Vicky L van Santen
Journal:  Vaccine       Date:  2017-09-09       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.